晨光生物(300138.SZ)发布前三季度业绩，归母净利润3.04亿元，增长385.3%

Core Viewpoint - Morning Light Bio (300138.SZ) reported a decrease in revenue for the first three quarters of 2025, while net profit saw a significant increase, indicating a potential shift in profitability despite declining sales [1] Financial Performance - The company's revenue for the first three quarters was 5.047 billion yuan, representing a year-on-year decrease of 3.41% [1] - Net profit attributable to shareholders reached 304 million yuan, showing a year-on-year increase of 385.30% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 256 million yuan, reflecting a substantial year-on-year growth of 1659.00% [1] - Basic earnings per share were reported at 0.63 yuan [1]